These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 35154068)
1. Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against Osero BO; Cele Z; Aruleba RT; Maine RA; Ozturk M; Lutz MB; Brombacher F; Hurdayal R Front Immunol; 2021; 12():759021. PubMed ID: 35154068 [TBL] [Abstract][Full Text] [Related]
2. Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection. Hurdayal R; Nieuwenhuizen NE; Revaz-Breton M; Smith L; Hoving JC; Parihar SP; Reizis B; Brombacher F PLoS Pathog; 2013 Oct; 9(10):e1003699. PubMed ID: 24204259 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory Dendritic Cells, Regulated by IL-4 Receptor Alpha Signaling, Control Replication, and Dissemination of Hurdayal R; Nieuwenhuizen NE; Khutlang R; Brombacher F Front Cell Infect Microbiol; 2019; 9():479. PubMed ID: 32039054 [TBL] [Abstract][Full Text] [Related]
4. Deletion of Interleukin-4 Receptor Alpha-Responsive Keratinocytes in BALB/c Mice Does Not Alter Susceptibility to Cutaneous Leishmaniasis. Govender M; Hurdayal R; Martinez-Salazar B; Gqada K; Pillay S; Gcanga L; Passelli K; Nieuwenhuizen NE; Tacchini-Cottier F; Guler R; Brombacher F Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30275010 [TBL] [Abstract][Full Text] [Related]
5. BALB/c mice deficient in CD4 T cell IL-4Rα expression control Leishmania mexicana Load although female but not male mice develop a healer phenotype. Bryson KJ; Millington OR; Mokgethi T; McGachy HA; Brombacher F; Alexander J PLoS Negl Trop Dis; 2011 Jan; 5(1):e930. PubMed ID: 21245915 [TBL] [Abstract][Full Text] [Related]
6. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection. Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591 [TBL] [Abstract][Full Text] [Related]
7. Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB/c mice. Masic A; Hurdayal R; Nieuwenhuizen NE; Brombacher F; Moll H PLoS Negl Trop Dis; 2012; 6(7):e1721. PubMed ID: 22802978 [TBL] [Abstract][Full Text] [Related]
8. Dectin-1 Positive Dendritic Cells Expand after Infection with Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U Front Immunol; 2018; 9():263. PubMed ID: 29535708 [TBL] [Abstract][Full Text] [Related]
9. House dust mite induced allergic airway disease is attenuated in CD11c Nieuwenhuizen NE; Kirstein F; Hoving JC; Brombacher F Sci Rep; 2018 Jan; 8(1):885. PubMed ID: 29343807 [TBL] [Abstract][Full Text] [Related]
10. IL-4-producing B cells regulate T helper cell dichotomy in type 1- and type 2-controlled diseases. Hurdayal R; Ndlovu HH; Revaz-Breton M; Parihar SP; Nono JK; Govender M; Brombacher F Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8430-E8439. PubMed ID: 28916732 [TBL] [Abstract][Full Text] [Related]
11. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility. Nagase H; Jones KM; Anderson CF; Noben-Trauth N J Immunol; 2007 Aug; 179(4):2435-44. PubMed ID: 17675505 [TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan. Halliday A; Bates PA; Chance ML; Taylor MJ Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391 [TBL] [Abstract][Full Text] [Related]
13. IL-4Ralpha responsiveness of non-CD4 T cells contributes to resistance in schistosoma mansoni infection in pan-T cell-specific IL-4Ralpha-deficient mice. Dewals B; Hoving JC; Leeto M; Marillier RG; Govender U; Cutler AJ; Horsnell WG; Brombacher F Am J Pathol; 2009 Aug; 175(2):706-16. PubMed ID: 19628763 [TBL] [Abstract][Full Text] [Related]
14. GK1 Improves the Immune Response Induced by Dendritic Cells of BALB/c Mice Infected with Leishmania mexicana Promastigotes. Gutiérrez-Kobeh L; Wilkins-Rodríguez AA Acta Parasitol; 2020 Mar; 65(1):27-35. PubMed ID: 31571138 [TBL] [Abstract][Full Text] [Related]
15. Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. Mohrs M; Ledermann B; Köhler G; Dorfmüller A; Gessner A; Brombacher F J Immunol; 1999 Jun; 162(12):7302-8. PubMed ID: 10358179 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection. Mohrs M; Holscher C; Brombacher F Infect Immun; 2000 Apr; 68(4):1773-80. PubMed ID: 10722563 [TBL] [Abstract][Full Text] [Related]
17. Leishmania mexicana induces limited recruitment and activation of monocytes and monocyte-derived dendritic cells early during infection. Petritus PM; Manzoni-de-Almeida D; Gimblet C; Gonzalez Lombana C; Scott P PLoS Negl Trop Dis; 2012; 6(10):e1858. PubMed ID: 23094119 [TBL] [Abstract][Full Text] [Related]
18. An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection. Alexander J; Brombacher F; McGachy HA; McKenzie AN; Walker W; Carter KC Eur J Immunol; 2002 Oct; 32(10):2923-33. PubMed ID: 12355446 [TBL] [Abstract][Full Text] [Related]
19. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Satoskar A; Bluethmann H; Alexander J Infect Immun; 1995 Dec; 63(12):4894-9. PubMed ID: 7591152 [TBL] [Abstract][Full Text] [Related]
20. FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions. Thomas BN; Buxbaum LU Infect Immun; 2008 Feb; 76(2):623-31. PubMed ID: 18070890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]